(Q45370788)

13 December 2017

title

Predictive value of tumor markers for hepatocarcinogenesis in patients with hepatitis C virus (English)

1 reference

13 December 2017

1 reference

1

Takashi Kumada

1 reference

13 December 2017

8

Junko Tanaka

1 reference

13 December 2017

7

Toshifumi Tada

1 reference

13 December 2017

2

Hidenori Toyoda

1 reference

13 December 2017

3

Seiki Kiriyama

1 reference

13 December 2017

4

Makoto Tanikawa

1 reference

13 December 2017

5

Yasuhiro Hisanaga

1 reference

13 December 2017

6

Akira Kanamori

1 reference

13 December 2017

Hiroshi Yoshizawa

9

1 reference

13 December 2017

publication date

7 December 2010

1 reference

Journal of Gastroenterology

13 December 2017

published in

1 reference

13 December 2017

volume

46

1 reference

13 December 2017

issue

4

1 reference

13 December 2017

page(s)

536-544

1 reference

Serum alpha-fetoprotein levels in acute viral hepatitis

13 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00535-010-0349-7

Serum alpha-fetoprotein levels in patients with acute and chronic liver disease. Relation to hepatocellular regeneration and development of primary liver cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-010-0349-7

Clinical outcomes after transfusion-associated hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-010-0349-7

Clinical significance of elevated alpha-fetoprotein (AFP) in patients with chronic hepatitis C, but not hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-010-0349-7

α-fetoprotein: Reevaluation in hepatology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-010-0349-7

Relation between incidence of hepatic carcinogenesis and integration value of alanine aminotransferase in patients with hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-010-0349-7

Incidence of hepatocellular carcinoma in hepatitis C carriers with normal alanine aminotransferase levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-010-0349-7

Correlation between ultrasonographic and pathologic diagnosis of liver fibrosis due to chronic virus hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-010-0349-7

Ultrasonographic and biochemical parameters in the non-invasive evaluation of liver fibrosis in hepatitis C virus chronic hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-010-0349-7

Imaging diagnosis of hepatocellular carcinoma and premalignant/borderline lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-010-0349-7

Effectiveness of periodic checkup by ultrasonography for the early diagnosis of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-010-0349-7

Serum alpha-fetoprotein levels in patients with advanced hepatitis C: results from the HALT-C Trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-010-0349-7

Sensitivity and specificity of des-gamma-carboxy prothrombin for diagnosis of patients with hepatocellular carcinomas varies according to tumor size

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-010-0349-7

Thrombocytopenia as a surrogate for cirrhosis and a marker for the identification of patients at high-risk for hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-010-0349-7

Mechanisms and implications of the age-associated decrease in DNA repair capacity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-010-0349-7

Interferon-induced prolonged biochemical response reduces hepatocarcinogenesis in hepatitis C virus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-010-0349-7

Interferon-alphaCon1 suppresses proliferation of liver cancer cell lines in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-010-0349-7

Interferon beta prevents recurrence of hepatocellular carcinoma after complete resection or ablation of the primary tumor-A prospective randomized study of hepatitis C virus-related liver cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-010-0349-7

Coarse Nodular US Pattern in Hepatic Cirrhosis: Risk for Hepatocellular Carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-010-0349-7

Biology of aging and cancer

21 January 2018

1 reference

12 December 2020

A multivariate analysis of risk factors for hepatocellular carcinogenesis: a prospective observation of 795 patients with viral and alcoholic cirrhosis

1 reference

12 December 2020

Hepatocellular carcinoma in Italian patients with cirrhosis

1 reference

12 December 2020

The role of hepatitis C virus in hepatocellular carcinoma in Japan

1 reference

12 December 2020

Serum alpha-fetoprotein levels and liver histology in patients with chronic hepatitis C.

1 reference

12 December 2020

Accurate preoperative evaluation of liver mass lesions without fine-needle biopsy

1 reference

12 December 2020

Alpha-fetoprotein (AFP) in benign liver disease. Evidence that normal liver regeneration does not induce AFP synthesis

1 reference

12 December 2020

Prognostic significance of simultaneous measurement of three tumor markers in patients with hepatocellular carcinoma

1 reference

12 December 2020

A decrease in AFP level related to administration of interferon in patients with chronic hepatitis C and a high level of AFP

1 reference

12 December 2020

Comparison of carbohydrate structures of serum alpha-fetoprotein by sequential glycosidase digestion and lectin affinity electrophoresis

1 reference

12 December 2020

Clinical, virologic, and pathologic significance of elevated serum alpha-fetoprotein levels in patients with chronic hepatitis C

1 reference

12 December 2020

Diagnosis and monitoring of hepatic injury. II. Recommendations for use of laboratory tests in screening, diagnosis, and monitoring

1 reference

12 December 2020

CT diagnosis of early hepatocellular carcinoma: sensitivity, findings, and CT-pathologic correlation

1 reference

12 December 2020

Diagnosis of small hepatocellular carcinoma: correlation of MR imaging and tumor histologic studies

1 reference

12 December 2020

The usefulness of determining des-gamma-carboxy prothrombin by sensitive enzyme immunoassay in the early diagnosis of patients with hepatocellular carcinoma

1 reference

12 December 2020

Classification of chronic hepatitis: diagnosis, grading and staging

1 reference

12 December 2020

Clinical utility of simultaneous measurement of serum high-sensitivity des-gamma-carboxy prothrombin and Lens culinaris agglutinin A-reactive alpha-fetoprotein in patients with small hepatocellular carcinoma

1 reference

12 December 2020

Development of hepatocellular carcinoma associated with increases in DNA synthesis in the surrounding cirrhosis

1 reference

12 December 2020

10.1007/S00535-010-0349-7

Identifiers

DOI

1 reference

13 December 2017

1 reference